Avacta Group Plc (AVCT):企業の製品パイプライン分析2018

【英語タイトル】Avacta Group Plc (AVCT) - Product Pipeline Analysis, 2018 Update

GlobalDataが出版した調査資料(DATA904C12183)・商品コード:DATA904C12183
・発行会社(調査会社):GlobalData
・発行日:2018年12月
・ページ数:40
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥222,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥333,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Avacta Group Plc (Avacta) is a developer therapeutic molecules used in a wide range of life sciences applications in research and diagnostics. The company offers products that include optim and sensipod. It also develops UCB celltech that is an analytical instrument. Avacta’s sensipod is an in-clinical blood testing system that delivers ELISA tests. The company offers intellectual property relating to an alternative to antibodies. It develops reagents and diagnostics that are used in affinity chromatography, protein to protein interactions, immunoassay and rapid diagnostic test applications, among others. It has operations in Wetherby, Cambridge and London. Avacta is headquartered in Wetherby, the UK.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Avacta Group Plc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Avacta Group Plc Company Overview 4
Avacta Group Plc Company Snapshot 4
Avacta Group Plc Pipeline Products and Ongoing Clinical Trials Overview 4
Avacta Group Plc – Pipeline Analysis Overview 6
Avacta Group Plc – Key Facts 6
Avacta Group Plc – Major Products and Services 7
Avacta Group Plc Pipeline Products by Development Stage 8
Avacta Group Plc Pipeline Products Overview 10
Depression Test 10
Depression Test Product Overview 10
Diagnostic Assay – Alzheimer’s Disease 11
Diagnostic Assay – Alzheimer’s Disease Product Overview 11
Diagnostic Test – ADHD 12
Diagnostic Test – ADHD Product Overview 12
Diagnostic Test – Bipolar Disorder 13
Diagnostic Test – Bipolar Disorder Product Overview 13
Point-Of-Care Diagnostic Test – Zika Virus 14
Point-Of-Care Diagnostic Test – Zika Virus Product Overview 14
Portable Pathogen Detection System 15
Portable Pathogen Detection System Product Overview 15
Rapid Diagnostic Test – Bacterial Strains 16
Rapid Diagnostic Test – Bacterial Strains Product Overview 16
Rapid Diagnostic Test – Infectious Diseases 17
Rapid Diagnostic Test – Infectious Diseases Product Overview 17
Schizophrenia Response Test 18
Schizophrenia Response Test Product Overview 18
Schizophrenia Side Effects Test 19
Schizophrenia Side Effects Test Product Overview 19
Avacta Group Plc – Key Competitors 20
Avacta Group Plc – Key Employees 21
Avacta Group Plc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 24
Avacta Group Plc, Recent Developments 24
Jun 11, 2018: Avacta Group Appointments Dr Eliot Forster As Non-Executive Chairman 24
Apr 16, 2018: Avacta Group Announces Interim Results for the Period Ended 31 January 2018 24
Mar 29, 2018: Avacta Group Announces Directorate Change 30
Jan 18, 2018: Avacta Group: AGM Business Update and Notice of Results 30
Dec 10, 2017: Avacta to Present Customer Data at Major US Conference 31
Nov 15, 2017: Covance to Present Affimer Data at European Conference 32
Oct 04, 2017: Avacta Group: Preliminary Results for the Year Ending 31 July 2017 32
Oct 02, 2017: Avacta Establishes US Business Development Team 33
Aug 07, 2017: Avacta Group: Trading Update and Notice of Results 34
May 10, 2017: Avacta Group: Key Affimer patent to be granted in China 35
Appendix 37
Methodology 37
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
Avacta Group Plc Pipeline Products and Ongoing Clinical Trials Overview 4
Avacta Group Plc Pipeline Products by Equipment Type 5
Avacta Group Plc Pipeline Products by Indication 5
Avacta Group Plc, Key Facts 6
Avacta Group Plc, Major Products and Services 7
Avacta Group Plc Number of Pipeline Products by Development Stage 8
Avacta Group Plc Pipeline Products Summary by Development Stage 9
Depression Test - Product Status 10
Depression Test - Product Description 10
Diagnostic Assay - Alzheimer's Disease - Product Status 11
Diagnostic Assay - Alzheimer's Disease - Product Description 11
Diagnostic Test - ADHD - Product Status 12
Diagnostic Test - ADHD - Product Description 12
Diagnostic Test - Bipolar Disorder - Product Status 13
Diagnostic Test - Bipolar Disorder - Product Description 13
Point-Of-Care Diagnostic Test - Zika Virus - Product Status 14
Point-Of-Care Diagnostic Test - Zika Virus - Product Description 14
Portable Pathogen Detection System - Product Status 15
Portable Pathogen Detection System - Product Description 15
Rapid Diagnostic Test - Bacterial Strains - Product Status 16
Rapid Diagnostic Test - Bacterial Strains - Product Description 16
Rapid Diagnostic Test - Infectious Diseases - Product Status 17
Rapid Diagnostic Test - Infectious Diseases - Product Description 17
Schizophrenia Response Test - Product Status 18
Schizophrenia Response Test - Product Description 18
Schizophrenia Side Effects Test - Product Status 19
Schizophrenia Side Effects Test - Product Description 19
Avacta Group Plc, Key Employees 21
Avacta Group Plc, Other Locations 22
Avacta Group Plc, Subsidiaries 22
Glossary 39

List of Figures
Avacta Group Plc Pipeline Products by Equipment Type 5
Avacta Group Plc Pipeline Products by Development Stage 8

★調査レポート[Avacta Group Plc (AVCT):企業の製品パイプライン分析2018] (コード:DATA904C12183)販売に関する免責事項を必ずご確認ください。
★調査レポート[Avacta Group Plc (AVCT):企業の製品パイプライン分析2018]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆